Appeal allowed on interest payment, dismissed on excessive remuneration & interest income.

The ITAT allowed the appeal for statistical purposes regarding the disallowance of interest payment to financial institutions, directing the AO to verify tax payments by the recipient institutions. However, the appeal was dismissed concerning the disallowance of excessive remuneration to a partner and the addition of interest income from M/s Yash Pharma. The ITAT upheld the decisions of the CIT(A) on these issues, emphasizing adherence to partnership deed terms and the accrual basis of taxation. Grounds 4 and 5 were dismissed for lack of arguments.

---

---

Issues Involved:
1. Disallowance of interest payment to financial institutions for non-deduction of tax at source.
2. Disallowance of excessive remuneration paid to a partner.
3. Addition of interest income from M/s Yash Pharma.
4. Denial of sufficient opportunity to present additional documents.
5. General request to amend, alter, or delete grounds of appeal.

Issue 1: Disallowance of Interest Payment to Financial Institutions:
The Assessing Officer disallowed an expenditure of &8377; 3,18,253 for interest paid to financial institutions due to non-deduction of tax at source. The CIT(A) partly allowed the appeal but confirmed this disallowance. The ITAT set aside the issue to verify if the recipient institutions paid taxes, directing the AO to delete the disallowance if taxes were paid and disclosed. The appeal was allowed for statistical purposes.

Issue 2: Disallowance of Excessive Remuneration to Partner:
The AO disallowed &8377; 2,36,916 as excessive remuneration paid to a partner, which was contested by the assessee. The CIT(A) upheld the disallowance based on the partnership deed terms. The ITAT affirmed the CIT(A)'s decision, stating that any payment exceeding the partnership deed terms is not allowable, even if the other partner agrees. The appeal was dismissed.

Issue 3: Addition of Interest Income from M/s Yash Pharma:
The AO added &8377; 20,000 as interest income from M/s Yash Pharma, which was contested by the assessee. The CIT(A) sustained the addition as the income was accrued during the year, following the mercantile system of accounting. The ITAT upheld this decision, emphasizing the accrual basis of taxation. The appeal was dismissed.

Issue 4 & 5: Denial of Sufficient Opportunity and General Request:
The ITAT dismissed Grounds 4 and 5 as no arguments were presented. The appeal was partly allowed for statistical purposes.

This judgment addressed various issues including disallowance of interest payment, excessive remuneration to a partner, addition of interest income, and procedural matters. The ITAT provided detailed analysis for each issue, considering legal provisions, partnership deed terms, and accounting principles to reach decisions. The judgment emphasized adherence to partnership agreements, tax implications, and proper accounting methods in determining the tax liabilities of the assessee.

---